The Cabinet Committee on Economic Affairs has approved foreign investment of up to Rs 9,589 crore in Suven Pharmaceuticals by Cyprus-based Berhyanda Limited. This Cabinet approval allows Berhyanda to acquire up to 76.1% equity shares of Suven Pharmaceuticals, potentially increasing the aggregate foreign investment in the company up to 90.1%.
